2 Reasons to Buy SpaceX Stock -- and 1 Reason to Wait

SpaceX shares have drifted down since the IPO (opened ~$150, closed ~ $142 on Aug. 28), while Starlink is cited as a bright spot: Q2 2026 Connectivity revenue was $4.3B (+66% YoY) and accounted for 55% of total revenue, with $1.7B operating income. However, SpaceX’s AI segment was loss-making (Q2 2026 revenue $2.6B vs operating loss of $1.3B) and capex remains very heavy ($15.8B in Q2 2026), with reported losses of $4.8B over H1 2026. Despite these fundamentals, the article flags a very rich valuation (about 90x trailing sales) and insider unlock-driven selling risk, implying a cautious entry point.

Analysis

The market is likely overpaying for scarcity and underpricing liquidity. The core issue is that once a high-multiple private name starts trading, the valuation tends to shift from story-driven optionality to float-driven price discovery; that usually compresses multiples before fundamentals can catch up. The near-term setup is therefore more about supply overhang and sentiment reset than about whether the business is good.

The connectivity franchise looks like the real economic engine, but it is also entering the phase where incremental growth depends on monetization quality, not just subscriber adds. That matters for competitors and adjacent suppliers: the durable beneficiaries are the picks-and-shovels names that sell compute, chips, spectrum-enabled infrastructure, and cloud capacity, while the integrator carries the capex and depreciation burden. In other words, if the AI spend is real, the cleaner exposure is GOOGL/NVDA-like infrastructure leverage, not the company doing the spending.

Catalyst-wise, insider unlocks create a 30-90 day risk window where supply can swamp narrative. Over 6-18 months, the thesis hinges on whether direct-to-cell materially expands the addressable market; absent that, the stock should trade more like a richly valued growth infrastructure asset than a perpetual scarcity premium. The contrarian miss is that a dominant market share is not the same as a still-expandable market—at this size, execution has to be near-perfect just to defend the multiple.

Key Decisions for Investors

• Short SPCX into unlock windows or on strength over the next 1-3 months; use the public-float expansion as the catalyst. Risk/reward favors the short if the name remains above 80x sales-equivalent on weak free-cash-flow visibility; invalidate if management shows accelerating operating leverage or the stock gaps up on materially better-than-expected lockup absorption.
• Buy 3-6 month SPCX put spreads rather than outright puts to express the valuation/liquidity overhang with defined carry. Best entry is after a post-unlock rally or failed breakout; thesis is falsified if shares hold above recent highs despite insider selling and no multiple compression.
• Pair trade: long NVDA / short SPCX as a cleaner exposure to AI capex. If the AI buildout is real, NVDA captures the capex while SPCX absorbs the burn; this pair should work over 1-3 months unless SPCX proves it can convert AI spend into high-margin recurring revenue.
• Watch GOOGL for spillover demand from compute/customer relationships, but do not chase until there is verifiable segment disclosure. If the company’s AI unit remains capex-heavy without margin expansion, treat it as a sentiment support, not a reason to own the equity.